BlossomHill Therapeutics Inc.

BLSM | NASDAQ

$26.66

-$0.14 (-0.52%)

Sep 22, 2026, 9:39 AM ET · Market open

Fiscal Quarter Period Ending	Q1 2026 Mar 30, 2026	Q1 2025 Mar 30, 2025
PE Ratio	-22.22	-44.44
PEG Ratio	n/a	n/a
PS Ratio	n/a	n/a
PB Ratio	-3.06	n/a
P/FCF Ratio	-22.21	-40.88
P/OCF Ratio	-22.22	-42.38
OCF/S Ratio	n/a	n/a
Debt / Equity Ratio	-0.15	n/a
Quick Ratio	7.40	n/a
Current Ratio	7.40	n/a
Asset Turnover	n/a	n/a
Interest Coverage	n/a	n/a
Return on Equity	13.81%	n/a
Return on Assets	-14.65%	n/a
Return on Invested Capital	-17.31%	n/a
Dividend Yield	n/a	n/a
Payout Ratio	n/a	n/a
FCF Payout Ratio	n/a	n/a
Gross Profit Margin	n/a	n/a
Net Profit Margin	n/a	n/a
Pretax Profit Margin	n/a	n/a
Operating Profit Margin	n/a	n/a
FCF Margin	n/a	n/a
EBITDA Margin	n/a	n/a